A case of liver damage caused by oral contraceptive agent (Anovlar)

A 34-year-old woman had pruritus and severe jaundice during the first cycle of treatment with Anovlar, a mixture of 4mg norethinsterone acetate as the progestogen and 0.05mg ethinvloestradiol as the estrogen. She had no history of exposure to other hepatotoxic agents and recurrent jaundice of pregna...

Full description

Saved in:
Bibliographic Details
Published inKanzo Vol. 18; no. 4; pp. 281 - 287
Main Authors SASAKI, Ryohmi, ARAKAWA, Yasuyuki, KATSUHARA, Tokumichi, KUWANA, Hitoshi, ITOH, Arata, ABE, Masanao, HASE, Masaru, YASUHIRO, Noriaki, JINNO, Daijoh, NISHIOKA, Shinya
Format Journal Article
LanguageJapanese
Published The Japan Society of Hepatology 1977
Subjects
Anavlar
Online AccessGet full text

Cover

Abstract A 34-year-old woman had pruritus and severe jaundice during the first cycle of treatment with Anovlar, a mixture of 4mg norethinsterone acetate as the progestogen and 0.05mg ethinvloestradiol as the estrogen. She had no history of exposure to other hepatotoxic agents and recurrent jaundice of pregnancy. The laboratory data included a elevated level of serum bilirubin and a slight increase of alkaline phosphatase activity. But other liver-function tests were normal except for BSP excretion. Drip intravenous cholangiography revealed no extrahepatic biliary obstruction. The clinical and biochemical findings suggested intrahepatic cholestatic jaundice, which disappeared within sixty days after withdrawal of the drug. A liver biopsy specimen showed intracellular bile stasis in the centrilobular zone and also bile thrombi in the dilated bile canaliculi. There were a scanty portal inflammation and the absence of proliferation of bile ducts and fibroblasts. The lymphoblastic transformation test to Anovlar was negative (below 5%). This suggests that Anovlar may exert a hepatotoxic effect.
AbstractList A 34-year-old woman had pruritus and severe jaundice during the first cycle of treatment with Anovlar, a mixture of 4mg norethinsterone acetate as the progestogen and 0.05mg ethinvloestradiol as the estrogen. She had no history of exposure to other hepatotoxic agents and recurrent jaundice of pregnancy. The laboratory data included a elevated level of serum bilirubin and a slight increase of alkaline phosphatase activity. But other liver-function tests were normal except for BSP excretion. Drip intravenous cholangiography revealed no extrahepatic biliary obstruction. The clinical and biochemical findings suggested intrahepatic cholestatic jaundice, which disappeared within sixty days after withdrawal of the drug. A liver biopsy specimen showed intracellular bile stasis in the centrilobular zone and also bile thrombi in the dilated bile canaliculi. There were a scanty portal inflammation and the absence of proliferation of bile ducts and fibroblasts. The lymphoblastic transformation test to Anovlar was negative (below 5%). This suggests that Anovlar may exert a hepatotoxic effect.
Author ARAKAWA, Yasuyuki
KUWANA, Hitoshi
HASE, Masaru
YASUHIRO, Noriaki
JINNO, Daijoh
KATSUHARA, Tokumichi
ITOH, Arata
SASAKI, Ryohmi
ABE, Masanao
NISHIOKA, Shinya
Author_xml – sequence: 1
  fullname: SASAKI, Ryohmi
  organization: 3rd Department of Internal Medicine, Nihon University School of Medicine
– sequence: 2
  fullname: ARAKAWA, Yasuyuki
  organization: 3rd Department of Internal Medicine, Nihon University School of Medicine
– sequence: 3
  fullname: KATSUHARA, Tokumichi
  organization: 3rd Department of Internal Medicine, Nihon University School of Medicine
– sequence: 4
  fullname: KUWANA, Hitoshi
  organization: 3rd Department of Internal Medicine, Nihon University School of Medicine
– sequence: 5
  fullname: ITOH, Arata
  organization: 3rd Department of Internal Medicine, Nihon University School of Medicine
– sequence: 6
  fullname: ABE, Masanao
  organization: 3rd Department of Internal Medicine, Nihon University School of Medicine
– sequence: 7
  fullname: HASE, Masaru
  organization: 3rd Department of Internal Medicine, Nihon University School of Medicine
– sequence: 8
  fullname: YASUHIRO, Noriaki
  organization: 3rd Department of Surgery, Nihon University School of Medicine
– sequence: 9
  fullname: JINNO, Daijoh
  organization: 3rd Department of Surgery, Nihon University School of Medicine
– sequence: 10
  fullname: NISHIOKA, Shinya
  organization: 3rd Department of Surgery, Nihon University School of Medicine
BookMark eNo9kE1LAzEQhoNUsNbe_AE5Krh1svnY5FhK_YCCFz2HbHZWV7fZkqyF-uvdutLLDMw87zA8l2QSuoCEXDNY5EYW918u_HQLphe5ZmdkyrRmGZeGT8gUhGSZyIFfkHlKTQmQqwKMyadktaTeJaRdTdtmj5FWbuvecRh-J6xoeaBddC31Xeij87jrB4gOQOjpzTJ0-9bF2ytyXrs24fy_z8jbw_p19ZRtXh6fV8tN5plUIVOFKnKUwqgq5zVzmgtQ4BBACYGVMQjCyxIK5qSssShlxauS1QY016UCPiN3410fu5Qi1nYXm62LB8vAHh3YPweWaTs4GPD1iH-mfvj4BLvYN77FEWZGwTEgxjLkTnv_4aLFwH8BuH1pNw
ContentType Journal Article
Copyright The Japan Society of Hepatology
Copyright_xml – notice: The Japan Society of Hepatology
DBID AAYXX
CITATION
DOI 10.2957/kanzo.18.281
DatabaseName CrossRef
DatabaseTitle CrossRef
DatabaseTitleList
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1881-3593
EndPage 287
ExternalDocumentID 10_2957_kanzo_18_281
article_kanzo1960_18_4_18_4_281_article_char_en
GroupedDBID AAOTG
ALMA_UNASSIGNED_HOLDINGS
CS3
JSF
KQ8
P2P
RJT
2WC
AAYXX
CITATION
OK1
ID FETCH-LOGICAL-c156n-67672e5496d23f1a834060ae00644ed99e04c5b071a55fe7b5d3db1f90838b603
ISSN 0451-4203
IngestDate Fri Aug 23 00:37:44 EDT 2024
Wed Apr 05 07:19:38 EDT 2023
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 4
Language Japanese
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c156n-67672e5496d23f1a834060ae00644ed99e04c5b071a55fe7b5d3db1f90838b603
OpenAccessLink https://www.jstage.jst.go.jp/article/kanzo1960/18/4/18_4_281/_article/-char/en
PageCount 7
ParticipantIDs crossref_primary_10_2957_kanzo_18_281
jstage_primary_article_kanzo1960_18_4_18_4_281_article_char_en
PublicationCentury 1900
PublicationDate 1977
PublicationDateYYYYMMDD 1977-01-01
PublicationDate_xml – year: 1977
  text: 1977
PublicationDecade 1970
PublicationTitle Kanzo
PublicationTitleAlternate Kanzo
PublicationYear 1977
Publisher The Japan Society of Hepatology
Publisher_xml – name: The Japan Society of Hepatology
References 2) Popper, H.: Drug-induced liver injury. In: The Liver, Edward, A. Gall, Williams & Wilkins Co., Baltimore, 1973, p. 182.
8) Schaffner. F., Changes in bile canaliculi produced by norethandrolone: Electron microscopic study of human and rat liver, J. Lab. Clin. Med., 56: 623, 1960.
27) Hoyumpa, A.M., Budd-Chiari syndrome in women taking oral contraceptives, Amer. J. Med., 50: 137, 1971.
9) Schaffner, F., Electron microscopy as related to hepatotoxicity, Ann. N. Y. Acad. Sci., 104: 847, 1963.
18) Ockner, R.K., Hepatic effect of oral contraceptives, New Engl. J. Med., 276: 331, 1967.
35) Perez, V., Female sex hormones and the liver. In: The Liver and its diseases, Fenton Schaffner Intercontinental Medical Book Co., New York, 1974, p. 179.
25) Gayson, M.J., Budd-Chiari syndrome after oral contraceptives, Brit. Med. J., 1: 512, 1968.
28) Tountas, C., Benign hepatoma and oral contraceptives, Brit. Med. J., 1: 1351, 1974.
17) Dalen, E., Occurrence of Hepatic impairment in women jaundiced by contraceptives and in their mothers and sisters, Acta Med. Scand., 195: 459, 1974.
29) Palva, I.P., Oral contraceptives and liver Damage, Brit. Med. J., 2: 688, 1964.
16) Orellana-Alcalde, .J.M.: Jaundice and oral contraceptive drugs, Lancet, 1: 1278, 1966.
38) Pihl, E., Functional and morphological liver changes in women taking oral contraceptives, Acta Chir. Scand., 134: 639, 1968.
24) Somayaji, B.N., Budd-Chiari syndrome after oral contraceptives, Brit. Med. J., 1: 53, 1968.
32) Boake, W.C., Intrahepatic cholestatic jaundice of pregnancy followed by Enovidinduced cholestatic jaundice, Ann. Int. Med., 63: 302, 1965.
34) Dooner, H.P., Jaundice and oral contraceptives, Acta Hepato-Splenol, 2: 84, 1971.
36) Schaffner, F.: The effect of oral contraceptives on the liver, J. A. M. A., 198: 155, 1966.
6) Klatskin, G.: Toxic and drug-induced hepatitis. In: Diseases of the liver, Leon Schiff, 3rd ed., Lippincott Co., Philadelphia, 1969, p. 498.
33) Eisalo, A.: Liver-function tests during intake of contraceptive tablets in pre-menopausal women, Brit. Med. J., 1: 1416, 1965.
15) Larsson-Cohn, U., Liver ultrastructure and function in icteric and non-icteric women during using oral contraceptives agents, Acta Med. Scand., 181: 257, 1967.
10) 市田文弘,他:Methandrostenolone投与による向鼠肝の微細構造の変化について.肝臓,6:331, 1965.
41) Mueller, M.N., Estrogen pharmacology. I. Influence of estradiol and estriol on hepatic disposal of sulfobromophthalein (BSP) in man, J. Clin. Invest., 43: 1905, 1964.
45) Kottra, H.L., Kappas, A.: Estrogen pharmacology. III. Effect of estradiol on plasma disappearance rate of sulfobromophthalein in man, Arch Int. Med., 117: 373, 1966.
7) Goldfischer, S., Cytochemical and electron microscopic studies of rat liver with reduced capacity to transport conjugated bilirubin, J. Exp. Med., 115: 467, 1962.
44) 丹羽正幸,他:経口避妊薬による中毒性肝障害経口避妊薬(Anavlar)による薬剤性肝傷害の1例57:287の1例.第139回日本消化器病学会関東甲信越地方会,1975.
42) Urban, E., Liver dysfunction with mestranol but not with norethynodrel in a patient with Enovidinduced jaundice, Ann. Int. Med., 68: 598, 1968.
26) Clubb, A.W., Budd-Chiari syndrome after oral contraceptives, Brit. Med. J., 1: 252, 1968.
39) Gallagher, T.F., Studies on mechanism and structural specificity of estrogen eggect on BSP metabolism, Tr. A. Am. Physicians, 78: 187, 1965.
3) Sherlock, S.: Drugs and the liver. In: Diseases of the liver and biliary system, Sherlock, S., 4th ed., Blackwell Scientific Publications Oxford & Edinburgh, 1968, p. 350.
19) Tyler, E.T.: Current status of Los Angeles oral contraception studies, App. Therap. 6: 507, 1964.
31) Baines, G.F.: Jaundice in a patient taking norethisterone cowpound tablets, Lancet, 1: 108, 1965.
14) Thulin, K.E., Seven cases of jaundice in women taking oral contraceptives, Anovlar, Brit. Med. J., 1: 584, 1966.
46) 佐々木博:ステロイドホルモンによる肝障害,織田敏次,他編,薬物と肝臓,中外医学社,東京,1975,p.206.
43) 外山久太郎,他:アノブラールによると思われる巨細胞性肝炎の1例.肝臓,15:386,1974.
23) Rothwell-Jackson, R.L.: Budd-Chiari syndrome after oral contraceptives, Brit. Med. J., 1: 252, 1968.
30) Fawcett, J.W., Oral contraceptives and liver damage, Brit. Med. J., 2: 755, 1966.
5) 三辺謙:諸種薬剤による肝障害.内科,23:292, 1969.
37) Perez, V., Oral contraceptives: longterm use produces fine structual changes in liver mitochondria, Science, 165: 805, 1969.
11) 症々木博,他:肝内胆汁うっ滞と黄疸発生-主として形態学的立場より.内科,34:370,1974.
13) Larsson-Cohn, U., Jaundice during treatment with oral contraceptive agents, J. A. M. A., 193: 422, 1965.
1) 鮫島美子,他:薬物性肝障害の臨床統計-日本における過去30年間の薬物性肝障害症例.日消会誌,71:799,1974.
4) Schaffner, F.: Therapeutic Agents and the Liver, Blackwell Scientific Publications, Oxford, 1965, p. 99.
20) Ecker, J.A., Thromboses of the hepatic veins: "The Budd-Chiari syndrome"-A possible link between oral contraceptives and thrombosis formation, Amer. J. Gastroent., 45: 429, 1966.
21) Baum, J.K., Possible association between benign hepatomas and oral contraceptives, Lancet II: 926, 1973.
22) Sterup, K., Budd-Chiari syndrome after taking oral contraceptives, Brit. Med. J., 4: 660, 1967.
12) Tyler, E.T. & Olson, H.J.: Fertility promoting and inhibiting effects of new steroid hormonal substances, J. A. M. A., 169: 129, 1959.
40) Gumucio, J. J., Studies on the mechanism of the ethynylestradiol impairment of bile flow and bile salt excretion in the rat, Gastroenterology, 61: 339, 1971.
References_xml
SSID ssib002670992
ssib000940394
ssib002670224
ssj0069113
ssib005879686
ssib002484534
ssib031783187
Score 1.2625308
Snippet A 34-year-old woman had pruritus and severe jaundice during the first cycle of treatment with Anovlar, a mixture of 4mg norethinsterone acetate as the...
SourceID crossref
jstage
SourceType Aggregation Database
Publisher
StartPage 281
SubjectTerms Anavlar
Title A case of liver damage caused by oral contraceptive agent (Anovlar)
URI https://www.jstage.jst.go.jp/article/kanzo1960/18/4/18_4_281/_article/-char/en
Volume 18
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX Kanzo, 1977/04/25, Vol.18(4), pp.281-287
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1db9MwFLXKQGgviE-x8SE_gASqUhLHTuwXpGgCFapNgrXa3io7cYB1axBtJpX_wH_mXjtNU-CBwUuUxk4k-55en2PfaxPyzJhcChkWAU-kDXhq88CUoFo114kpJcixHIXi4VEynPD3p-K01_vRiVqql2aQf_9jXsm_WBWegV0xS_YKlm0_Cg_gHuwLV7AwXP_Kxlk_134u_hzDK_qFvsAQnFzXC08sXfq9i0bXLnzl0vb1p2aTURD-l-cYXq26BHUEXLFqp12y42z0zllhVX2--NKi42M2yk4y5771ol7Vs7ZolI2PJ0Oo4IBQzWqczNyUTk6yI1c0BE-yaAoKn4XXHLTSJqzBMD5vo0pxvQFGzuVmFcB7Ly5AnLLQey_rvauUURALfyTi7-53M7fgfak_y6UZlpkfl3_1-Ey5Y4pn2DmDSA7al7b20G4sNHXVwOeA8JFT7i_wxnRdjpluAKxr5DrDfQNxjf9Dh60qHsZdNcwlF3FXzabIiLZ-q86itZCpSja79QFzk-BR2_mBBMYdFxCx7jmfp4EtfNVt3xaDunEGImIdgOg40fg2udWIGZr5dt0hvTN9l9w8bMI17pGDjCJAaVVSB1DqAUo9QKlZUQQo3QIodQClLxp4vrxPJm_fjA-GQXNqR5BHIpkHuAMgs4KrpGBxGWkZA2cMtUXyy22hlA15LgxQWy1EaVMjirgwUalADEiThPEDsjOv5vYhobliKEgYS0XJWZmouNAFMGrNQRLKuNwjz9c9Mf3qN2eZgqjFHvOmRgtDj-2R176b2lpXBMT-_37gEdnFv5Gfu3tMdpbfavsE2OzSPHUY-wkx2pgl
link.rule.ids 315,783,787,4033,27937,27938,27939
linkProvider Colorado Alliance of Research Libraries
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+case+of+liver+damage+caused+by+oral+contraceptive+agent+%28Anovlar%29&rft.jtitle=Kanzo&rft.au=SASAKI%2C+Ryohmi&rft.au=ARAKAWA%2C+Yasuyuki&rft.au=KATSUHARA%2C+Tokumichi&rft.au=KUWANA%2C+Hitoshi&rft.date=1977&rft.pub=The+Japan+Society+of+Hepatology&rft.issn=0451-4203&rft.eissn=1881-3593&rft.volume=18&rft.issue=4&rft.spage=281&rft.epage=287&rft_id=info:doi/10.2957%2Fkanzo.18.281&rft.externalDocID=article_kanzo1960_18_4_18_4_281_article_char_en
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0451-4203&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0451-4203&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0451-4203&client=summon